Burden of congenital rubella syndrome (CRS) in India based on data from cross-sectional serosurveys, 2017 and 2019–20

BACKGROUND: India has set a goal to eliminate measles and rubella/Congenital Rubella Syndrome (CRS) by 2023. Towards this goal, India conducted nationwide supplementary immunization activity (SIA) with measles-rubella containing vaccine (MRCV) targeting children aged between 9 months to <15 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanmugasundaram, Devika, Awasthi, Shally, Dwibedi, Bhagirathi, Geetha, S., Jain, Manish, Malik, Shikha, Patel, Bhupeshwari, Singh, Himabindu, Tripathi, Shalini, Viswanathan, Rajlakshmi, Agarwal, Anjoo, Bonu, Rajeswari, Jain, Shuchi, Jena, Saubhagya Kumar, Priyasree, J., Pushpalatha, K, Ali, Syed, Biswas, Debasis, Jain, Amita, Narang, Rahul, Madhuri, Sudha, George, Suji, Kaduskar, Ojas, Kiruthika, G., Sabarinathan, R., Sapakal, Gajanan, Gupta, Nivedita, Murhekar, Manoj V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376255/
https://www.ncbi.nlm.nih.gov/pubmed/34297716
http://dx.doi.org/10.1371/journal.pntd.0009608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376255/
https://www.ncbi.nlm.nih.gov/pubmed/34297716
http://dx.doi.org/10.1371/journal.pntd.0009608

Ejemplares similares